Sharewise Presentation 22/7/24, page-81

So you make a good point @thenewinvest0r, especially on the heels of finally stating what they are modelling for costs.
He said they thought costs for P3 completion would be US$50 - $60m, the presentation showed 400 n (which many have pointed out), so the math works out to be circa US$150,000 per patient, that is a rather staggering number.
We were always guessing how much they previously spent and how much the extra screening (retinal etc) was costing.
I sure hope that 400 n for the next part of P3 is correct, otherwise that $150,000 per head is going to blowout total costs very quickly.